Genetics and new treatment modalities for familial Mediterranean fever

Annals of the New York Academy of Sciences

Volumn 1110, Issue , 2007, Pages 201-208

  Bhat, Anupama ^a   Naguwa, Stanley M ^a   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloidosis; Colchicine; Familial Mediterranean fever; Interferon ; Pyrin

Indexed keywords

ALPHA INTERFERON; COLCHICINE; ETANERCEPT; PLACEBO; PRAZOSIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; THALIDOMIDE; TUMOR NECROSIS FACTOR;

ABDOMINAL PAIN; AMYLOIDOSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DOWN REGULATION; ERYSIPELAS; FAMILIAL MEDITERRANEAN FEVER; FEVER; GENETIC DISORDER; HUMAN; IMMUNOLOGY; KIDNEY FAILURE; KNEE ARTHRITIS; MONOTHERAPY; MYALGIA; PERICARDITIS; PLEURISY; SKIN DEFECT; SPLENOMEGALY;

EID: 35748931764     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1423.022     Document Type: Conference Paper

References (27)

1. DRENTH, JOOST P.H. & JOS W.M. VAN DER MEER 2001. Hereditary periodic fever. N. Engl. J. Med. 345: 1748-1757.
2. TUNCA, M. & H. OZDOGAN. 2005. Molecular and Genetic Characteristics of Hereditary Autoinflammatory Diseases Inflammation & Allergy 4(1).
3. PRAS, E., I. AKSENTIJEVICH, L. GRUBERG et al. 1992. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N. Engl. J. Med. 326: 1507-1513.
4. TOUITOU, I., S. LESAGE, M. MCDERMOTT, et al. 2004. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum. Mutat. 24: 194-198.
5. JOHN MEYERHOFF. M.D., Mediterranean fever, familial. emedicine 2006.
6. AKSENTIJEVICH, I., Y. TOROSYAN, J. SAMUELS & M. CENTOLA. 1999. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am. J. Hum. Genet. 64: 949-962.
7. LICHTMAN, M.A. et al., Eds. 2007. Familial Mediterranean fever: etiology and diagnosis. InWilliams Hematology, 7th Ed., Chapt. 66. McGraw-Hill. New York.
8. BEN-CHETRIT, E. & M. SAGI. 2001. British Society of Rheumatology; genetic counselling in familial Mediterranean fever: has the time come? Rheumatology 40: 606-609.
9. BEN-CHETRIT, E. & M. LEVY. 1998. Familial Mediterranean fever. Lancet 351: 659-664.
10. BARAKAT, M.H., A.O. EL-KHAWAD, K.A. GUMAA, et al. 1984. Metaraminol provocative test: a specific diagnostic test for familial Mediterranean fever. Lancet i: 656-657.
11. TOUITOU, I. 2001. The spectrum of familial Mediterranean fever (FMF) mutations. Eur. J. Hum. Genet. 9: 473-483.
12. Familial Mediterranean Fever. In Merck Manual of Diagnosis and Therapy, the 18th ed. Merck & Co., Rahway, NY.
13. KATAOKA, H., H. KUMAGAI & H. HANAI. 1998. Treating familial Mediterranean fever with prazosin hydrochloride. Ann. Int. Med. 129: 424-425.
14. TUNCA, M., S. AKAR, M. SOYTURK, et al. 2004. The effect of interferon alpha administration on acute attacks of familial Mediterranean: a double-blind, placebo-controlled trial. Clin. Exp. Rheum. 22(4 Suppl 34): S37-S40.
15. SEYAHI, E., H. OZDOGAN, S. CELIK, et al.. 2006. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin. Exp. Rheum. 24(5 Suppl 42): S099-S103.
16. LIVNEH, A. & P. LANGEVITZ. 2000. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract. Res. Clin. Rheumatol. 14: 477-498.
17. BAR-ELI, M., M. EHRENFELD, M. LEVY, et al. 1981. Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever). Am. J. Med. Sci. 281: 15-18.
18. LANGEVITZ, P., D. ZEMER, A. LIVNEH, et al. 1994. Protracted febrile myalgia in patients with familial Mediterranean fever. J. Rheumatol. 21: 1708-1709.
19. PRAS, E., P. LANGEVITZ, A. LIVNEH, et al. 1997. Genotype-phenotype correlation in familial Mediterranean fever: a preliminary report. In Proceedings of the First International Conference on FMF (Jerusalem, 1997). E. Sohar, J. Gafni and M. Pras, Eds.: 260-264. Freund, Tel Aviv.
20. CHAE, J.J., G. WOOD, S.L. MASTERS, et al. 2006. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc. Natl. Acad. Sci. USA 103: 9982-9987.
21. ROZENBAUM, M., R. KATZ, I. ROZNER, et al. 1992. Decreased interleukin I activity released from circulating monocytes of patients with familial Mediterranean fever during in vitro stimulation by lipopolysaccharide. J. Rheumatol. 19: 416-418.
22. KEES, S., P. LANGEVITZ, D. ZEMER, et al. 1997. Attacks of pericarditis as a manifestation of familial Mediterranean fever. QJM 90: 643-647.
23. GRATEAU, G. 2006. Autoinflammatory diseases [review]. Acta Clin. Belg. 61: 264-269.
24. GALEAZZI, M., G. GASBARRINI, A. GHIRARDELLO, et al. 2006. Autoinflammatory syndromes. Clin. Exp. Rheumatol. 24(1 Suppl 40): S79-S85.
25. MEDLEJ-HASHIM, M., J. LOSSELET, G. LEFRANC & A. MEGARBANE. 2004. Pub med: Sante 14 FMF-diagnosis to treatment.
26. MOR, A., M.H. PILLINGER, M. KISHIMOTO, et al. 2007. Familial Mediterranean fever successfully treated with etanercept. J. Clin. Rheum. 13: 38-40.
27. SEYAHI, E., H. OZDOGAN, S. MASATLIOGLU & H.YAZICI. 2002. Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient. Clin. Exp. Rheumatol. 20(Suppl. 26): S43-S44.